Targeted therapies for autoimmune/idiopathic nonmalignant diseases: risk and management of opportunistic infections

DF Bavaro, D Fiordelisi, G Angarano… - Expert opinion on …, 2020 - Taylor & Francis
Introduction The management of patients affected by autoimmune/idiopathic diseases has
been revolutionized by the development of targeted therapies (TT). However, the use of TT …

Nontuberculous mycobacterial skin and soft tissue infection in Hawaiʻi

DS Tokunaga, AM Siu, SY Lim - BMC Infectious Diseases, 2022 - Springer
Background Hawaiʻi has the highest nontuberculous mycobacterial (NTM) lung infection
prevalence in the United States. Limited data regarding skin and soft tissue infections (SSTI) …

The bacterial and host factors associated with extrapulmonary dissemination of Mycobacterium tuberculosis

D Yang, Y Kong - Frontiers in biology, 2015 - Springer
With high morbidity and mortality worldwide, tuberculosis (TB) is still an important public
health threat. The majority of human TB cases are caused by Mycobacterium tuberculosis …

Molecular identification of non-tuberculous mycobacterial species isolated from extrapulmonary samples using real-time PCR and rpoB sequence analysis

M Hashemzadeh, AA Dezfuli, AD Khosravi… - AMB Express, 2023 - Springer
Tuberculosis (TB) is one of the leading causes of mortality among infectious diseases and
accounts for a serious health hazard wordwide. Apart from TB, the members of non …

Association of tumor necrosis factor inhibitors with the risk of nontuberculous mycobacterial infection in patients with rheumatoid arthritis: a nationwide cohort study

HJ Park, B Choi, YK Song, YJ Oh, EB Lee… - Journal of Clinical …, 2023 - mdpi.com
Tumor necrosis factor inhibitors (TNFi) are proposed as a risk factor for nontuberculous
mycobacteria (NTM) infection. Limited research investigates NTM infection risk in …

[HTML][HTML] Host immune response against environmental nontuberculous mycobacteria and the risk populations of nontuberculous mycobacterial lung disease

CC Shu, MF Wu, SW Pan, TS Wu, HC Lai… - Journal of the Formosan …, 2020 - Elsevier
Nontuberculous mycobacterial lung disease (NTM-LD) prevalence has been increasing
over the recent decades. Numerous host factors are associated with NTM-LD development …

Omadacycline for management of Mycobacteriumabscessus infections: a review of its effectiveness, place in therapy, and considerations for use

AR Rizzo, NH Moniri - BMC Infectious Diseases, 2022 - Springer
The Mycobacterium abscessus complex (MABC) is a group of acid-fast, rapidly dividing non-
tuberculous mycobacteria (NTM) that include a number of clinically important subspecies …

A prospective study of non-tuberculous mycobacterial disease among tuberculosis suspects at a tertiary care centre in north India

SK Sharma, R Sharma, BK Singh… - Indian Journal of …, 2019 - journals.lww.com
Methods: In this prospective study, mycobacterial culture isolates from pulmonary and
extrapulmonary specimens among TB suspects were tested with immunochromatographic …

Airborne infectious agents and other pollutants in automobiles for domestic use: potential health impacts and approaches to risk mitigation

SA Sattar, KE Wright, B Zargar… - … of Environmental and …, 2016 - Wiley Online Library
The world total of passenger cars is expected to go from the current one billion to> 2.5 billion
by 2050. Cars for domestic use account for~ 74% of the world's yearly production of …

Unusual prophages in Mycobacterium abscessus genomes and strain variations in phage susceptibilities

ED Amarh, RM Dedrick, RA Garlena, DA Russell… - PLoS …, 2023 - journals.plos.org
Mycobacterium abscessus infections are relatively common in patients with cystic fibrosis
and are clinically challenging, with frequent intrinsic resistance to antibiotics. Therapeutic …